Infusion of bcr/abl peptide-reactive donor T cells to achieve molecular remission of chronic myeloid leukemia after CD34+ selected allogeneic hematopoietic cell transplantation

被引：3
作者：
Bornhauser, M. [1 ]
Thiede, C.
Babatz, J.
Schetelig, J.
Illmer, T.
Kiani, A.
Platzbecker, U.
Herr, W.
Rieber, E. -P.
Ehninger, G.
Schmitz, M.
机构：
[1] Univ Hosp Dresden, Med Klin & Poliklin 1, Dresden, Germany
[2] Univ Hosp Mainz, Med Klin & Poliklin 3, Mainz, Germany
[3] Univ Hosp Dresden, Inst Immunol, Dresden, Germany
来源：
LEUKEMIA | 2006年 / 20卷 / 11期
关键词：
D O I：
10.1038/sj.leu.2404383
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：2055 / 2057
页数：4
相关论文
共 11 条
[1]   Induction of cellular immune responses against carcinoembryonic antigen in patients with metastatic tumors after vaccination with altered peptide ligand-loaded dendritic cells [J].
Babatz, J ;
Röllig, C ;
Löbel, B ;
Folprecht, G ;
Haack, M ;
Günther, H ;
Köhne, CH ;
Ehninger, G ;
Schmitz, M ;
Bornhäuser, M .
CANCER IMMUNOLOGY IMMUNOTHERAPY, 2006, 55 (03) :268-276
[2]  
Butt NM, 2005, HAEMATOLOGICA, V90, P1315
[3]   Outcome of transplantation of highly purified peripheral blood CD34+ cells with T-cell add-back compared with unmanipulated bone marrow or peripheral blood stem cells from HLA-identical sibling donors in patients with first chronic phase chronic myeloid leukemia [J].
Elmaagacli, AH ;
Peceny, R ;
Steckel, N ;
Trenschel, R ;
Ottinger, H ;
Grosse-Wilde, H ;
Schaefer, UW ;
Beelen, DW .
BLOOD, 2003, 101 (02) :446-453
[4]   Complete remission of accelerated phase chronic myeloid leukemia by treatment with leukemia-reactive cytotoxic T lymphocytes [J].
Falkenburg, JHF ;
Wafelman, AR ;
Joosten, P ;
Smit, WM ;
van Bergen, CAM ;
Bongaerts, R ;
Lurvink, E ;
van der Hoorn, M ;
Kluck, P ;
Landegent, JE ;
Kluin-Nelemans, HC ;
Fibbe, WE ;
Willemze, R .
BLOOD, 1999, 94 (04) :1201-1208
[5]   Mechanisms of disease - Chronic myeloid leukemia - Advances in biology and new approaches to treatment [J].
Goldman, JM ;
Melo, JV .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (15) :1451-1464
[6]   Prostate stem cell antigen:: Identification of immunogenic peptides and assessment of reactive CD8+ T cells in prostate cancer patients [J].
Kiessling, A ;
Schmitz, M ;
Stevanovic, S ;
Weigle, B ;
Hölig, K ;
Füssel, M ;
Füssel, S ;
Meye, A ;
Wirth, MP ;
Rieber, EP .
INTERNATIONAL JOURNAL OF CANCER, 2002, 102 (04) :390-397
[7]  
Luznik Leo, 2002, Cancer Control, V9, P123
[8]   T-CELL DEPLETION OF HLA-IDENTICAL TRANSPLANTS IN LEUKEMIA [J].
MARMONT, AM ;
HOROWITZ, MM ;
GALE, RP ;
SOBOCINSKI, K ;
ASH, RC ;
VANBEKKUM, DW ;
CHAMPLIN, RE ;
DICKE, KA ;
GOLDMAN, JM ;
GOOD, RA ;
HERZIG, RH ;
HONG, R ;
MASAOKA, T ;
RIMM, AA ;
RINGDEN, O ;
SPECK, B ;
WEINER, RS ;
BORTIN, MM .
BLOOD, 1991, 78 (08) :2120-2130
[9]   Evidence that specific T lymphocytes may participate in the elimination of chronic myelogenous leukemia [J].
Molldrem, JJ ;
Lee, PP ;
Wang, CQ ;
Felio, K ;
Kantarjian, HM ;
Champlin, RE ;
Davis, MM .
NATURE MEDICINE, 2000, 6 (09) :1018-1023
[10]   b3a2 BCR-ABL fusion peptides as targets for cytotoxic T cells in chronic myeloid leukaemia [J].
Norbury, LC ;
Clark, RE ;
Christmas, SE .
BRITISH JOURNAL OF HAEMATOLOGY, 2000, 109 (03) :616-621
12